These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16226079)

  • 41. Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
    Jæger KH; Wall S; Tveito A
    PLoS Comput Biol; 2021 Feb; 17(2):e1008089. PubMed ID: 33591962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and management of short QT syndrome.
    Bjerregaard P
    Heart Rhythm; 2018 Aug; 15(8):1261-1267. PubMed ID: 29501667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short QT syndrome.
    Brugada R; Hong K; Cordeiro JM; Dumaine R
    CMAJ; 2005 Nov; 173(11):1349-54. PubMed ID: 16301704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful elimination of significant arrhythmia burden with flecainide in an adolescent with long QT syndrome type 3.
    Kilinc OU; Tuzcu V
    Congenit Heart Dis; 2012; 7(4):E42-5. PubMed ID: 22129298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief review of the recently described short QT syndrome and other cardiac channelopathies.
    Pérez Riera AR; Ferreira C; Dubner SJ; Schapachnik E; Soares JD; Francis J
    Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):371-7. PubMed ID: 16029390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short QT syndrome: mechanisms, diagnosis and treatment.
    Bjerregaard P; Gussak I
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):84-7. PubMed ID: 16265378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.
    Patel C; Antzelevitch C
    Heart Rhythm; 2008 Apr; 5(4):585-90. PubMed ID: 18362027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
    Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
    Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quinidine in short QT syndrome: an old drug for a new disease.
    Kaufman ES
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):665-6. PubMed ID: 17521305
    [No Abstract]   [Full Text] [Related]  

  • 54. Short QT syndrome.
    Bjerregaard P; Gussak I
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):436-40. PubMed ID: 16255754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome.
    Iijima K; Chinushi M; Hasegawa K; Izumi D; Hosaka Y; Furushima H; Aizawa Y
    Intern Med; 2011; 50(9):1021-4. PubMed ID: 21532225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome.
    El-Battrawy I; Besler J; Liebe V; Schimpf R; Tülümen E; Rudic B; Lang S; Wolpert C; Zhou X; Akin I; Borggrefe M
    J Am Heart Assoc; 2018 Dec; 7(23):e010073. PubMed ID: 30571592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    Mazzanti A; Maragna R; Vacanti G; Kostopoulou A; Marino M; Monteforte N; Bloise R; Underwood K; Tibollo V; Pagan E; Napolitano C; Bellazzi R; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2017 Dec; 70(24):3010-3015. PubMed ID: 29241489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short QT syndrome: from bench to bedside.
    Patel C; Yan GX; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):401-8. PubMed ID: 20716721
    [No Abstract]   [Full Text] [Related]  

  • 59. [Short QT syndrome as an inherited condition].
    Møller DV; Hedley PL; Olesen M; Kanters J; Svendsen JH; Christiansen M
    Ugeskr Laeger; 2011 Feb; 173(6):420-4. PubMed ID: 21299935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short QT syndrome in pediatrics.
    Pereira R; Campuzano O; Sarquella-Brugada G; Cesar S; Iglesias A; Brugada J; Cruz Filho FES; Brugada R
    Clin Res Cardiol; 2017 Jun; 106(6):393-400. PubMed ID: 28303324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.